Position in TRVI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,790,161
New position
Shares Held
317,700
first reported quarter
Ownership
0.224%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026GMT Capital Corp holds $123,541,469 across 6 Biotechnology names. TRVI ranks #3 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
581,000 | $109,838,050 | |
| 2 | OCGN |
Ocugen, Inc.
|
3,505,398 | $6,344,770 | |
| 3 | TRVI |
Trevi Therapeutics, Inc.
This page
|
317,700 | $3,790,161 | |
| 4 | PGEN |
Precigen, Inc.
|
668,830 | $2,588,372 | |
| 5 | FLNA |
Filana Therapeutics, Inc.
|
450,100 | $760,669 | |
| 6 | INO |
Inovio Pharmaceuticals, Inc.
|
126,119 | $219,447 |
All Filings in TRVI
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,790,161 | 317,700 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||